CytoReason

About:

CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.

Website: http://www.cytoreason.com

Twitter/X: Cytoreason

Top Investors: NVIDIA, Pfizer, OurCrowd, Thermo Fisher Scientific, Asymmetry Ventures

Description:

CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data. The company collects proprietary data from pharma companies and uses it to simulate human diseases tissue by tissue, cell by cell. With CytoReason’s massive database and AI-led platform, pharma and biotech companies identify new opportunities, shorten trial phases, reduce development costs and increase the likelihood of approval.

Total Funding Amount:

$100M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Tel Aviv, Tel Aviv, Israel

Founded Date:

2016-09-01

Contact Email:

zeev.benshachar(AT)cytoreason.com

Founders:

David Harel, Elina Starosvetsky, Ksenya Kveler, Renaud Gaujoux, Shai Shen-Orr, Yuval Kalugny

Number of Employees:

101-250

Last Funding Date:

2024-07-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai